U-BX Technology Ltd. (UBXG) focuses on artificial intelligence-driven value-added services for the insurance industry in China. The company provides digital promotion services, risk assessment tools such as its Magic Mirror algorithm for payout risk calculation, and bundled benefits like auto maintenance and vehicle notifications to insurance carriers and brokers. Founded in 2018 and based in Beijing, U-BX competes in the software-infrastructure sector by using AI to improve underwriting and customer engagement. From what I see, its fundamentals— including a low price-to-sales ratio of 0.09 and exposure to China's vast insurance market—have helped support the recent stock price recovery as investors turn toward undervalued tech opportunities with growth potential in insurtech.
In the last 30 days, UBXG stock rose +79%, moving from a close of $1.87 around early March to $3.34 by March 31. The advance was volatile and trend-driven, starting with low daily volumes that gave way to a massive spike of over 296,000 shares on the final day, which drove the price from an open of $1.78 to a high of $3.34.
Over the quarter, the stock gained +61%, climbing from $2.08 in early January to the recent $3.34 close. It stayed range-bound early before picking up speed, trading near the lower end of its 52-week range of $1.45-$4.55. The 50-day moving average is around $1.82, which confirms the bullish breakout.
The sharp +79% rally in UBXG over the past 30 days came mainly from increased trading activity and speculative interest in small-cap tech stocks. Volume surged on March 31 to 296,400 shares—well above the average of around 6,000—alongside an intraday gain of over 100%, pointing to momentum buying. This played out amid broader market trends favoring AI and insurtech, where U-BX's specialized services drew notice. No specific company news, such as earnings or partnerships, surfaced during the period, but the stock's negative beta of -1.38 amplified the upside during risk-on shifts. With a low float of 22.5 million shares, limited supply intensified the volatility as demand picked up.
I also checked this using Tickeron’s AI Screener to compare how UBXG stacks up against peers in the industry.
The +61% quarterly uptrend for UBXG reflects ongoing interest in its role within China's insurance tech space, where AI adoption is gaining speed. Earlier concerns from Nasdaq minimum bid price compliance notices—addressed through a 1-for-16 reverse split in late 2024—had pressured sentiment, but holding above $1.45 attracted institutional buyers. Macro tailwinds, like stabilizing interest rates and demand for cost-efficient insurtech amid China's economic recovery, aided the rebound. Declining short interest and YTD returns of +67% show investors warming to micro-cap recovery plays. Overall, sector momentum has outweighed challenges like the -9.16% profit margin.
In my research, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots from hundreds that scan and trade thousands of tickers across markets. These bots are selected based on recent performance, win rates, and fit with current conditions, covering strategies from short-term scalping to long-term trends, with different timeframes, risk levels, and focuses like stocks, ETFs, or forex. I find it useful to review their stats, backtests, and live results to match tools with stocks like UBXG that can swing on volume. It's one resource I rely on to stay ahead in spotting patterns early.
One thing that stands out for investors is the upcoming fiscal year-end results on June 30, where profitability metrics like ROA (-10.28%) and ROE (-16.53%) will be in focus. Nasdaq compliance remains a priority after prior notices, especially bid price and market value rules. Trends in Chinese insurtech—such as AI regulations and competition—could influence sentiment, as could U.S.-China trade dynamics, interest rates affecting insurance demand, and tech sector rotations. I'm watching volume trends and any strategic developments like partnerships or shelf offerings, which could add volatility.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The 10-day RSI Oscillator for UBXG moved out of overbought territory on April 01, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 instances where the indicator moved out of the overbought zone. In of the 9 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on April 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UBXG as a result. In of 35 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for UBXG turned negative on April 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 17 similar instances when the indicator turned negative. In of the 17 cases the stock turned lower in the days that followed. This puts the odds of success at .
UBXG moved below its 50-day moving average on April 02, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBXG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
UBXG broke above its upper Bollinger Band on March 31, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for UBXG entered a downward trend on March 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11 3-day Advance, the price is estimated to grow further. Considering data from situations where UBXG advanced for three days, in of 93 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.868) is normal, around the industry mean (36.125). UBXG has a moderately high P/E Ratio (856.281) as compared to the industry average of (133.541). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.368). UBXG has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.028). P/S Ratio (0.906) is also within normal values, averaging (153.522).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. UBXG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UBXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications